ArticleRSC advances2022
Two-photon absorption of 28-hetero-2,7-naphthiporphyrins: expanded carbaporphyrinoid macrocycles.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers.Current treatment options in oncology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The one- and two-photon absorption (1PA and 2PA) properties of three expanded aceneporphyrinoids, 28-thia-, 28-selena- and 28-tellura-2,7-naphthiporphyrin, have been studied. The open-aperture Z-scan technique was used to determine two-photon absorption cross-sections in the near infrared range using an amplified femtosecond laser system. The maximum values of the cross sections were found to be 99, 200 and 650 GM at 900 nm and 1, 13 and 31 GM at 1400 nm for the three investigated compounds, respectively. These results demonstrate enhanced 2PA properties compared with well-known porphyrin photosensitizers, such as Foscan®, showing the potential of porphyrin core modification for optimizing infrared nonlinear absorbers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.